ALISON MILLER: Open Payments
NPI 1528662517 · PARIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| ABBVIE INC. | 4 | $78 |
| Biogen, Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, TYSABRI, COBENFY, TRINTELLIX, Qelbree.
Industry payments across TN — which companies pay providers there.
